Additional functional assays included IFN-γ/IL-2 ELISA and cytotoxicity assays.<h4>Results</h4>SLC12A8 was significantly upregulated in breast cancer tissues and cell lines, and its high expression correlated with poor patient prognosis. The gene discussed is IL2; the disease is breast carcinoma.